MedPath

Meningitis With Cerebral Vasculitis in Children

Completed
Conditions
Bacterial Meningitis
Registration Number
NCT03595761
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Purulent meningitis are life-threatening diseases in childhood. Cerebral vasculitis have been described in bacterial meningitis, but poor is known about their physiology and their impact on outcome.

The investigators decide to realize a retrospective mono-centric study carried out at Montpellier university hospital which looks back at a 7-year study(2009-2016).

The Investigators selected purulent meningitis cases based on the bacteriological data provided by the HDB (hospital data base). The Investigators divides in two groups : Group A if patients present a cerebral vasculitis ( radiologic diagnostic by RMI or tomodensitometry), in all, cases the diagnosis of vasculitis was confirmed by a radiologist specialised in neuropaediatrics by a second reading;Group B purulent meningitis with a cerebral vasculitis imaging.

Tuberculous meningitis, meningitis in CSF shunt, and in patients having chemotherapy were excluded.

The investigators report clinical and biological finding, inflammatory marker at the onset. The Investigators register also the clinical evolution and sequelae

Detailed Description

Meningitis steel are a cause of death in childhood. Cerebral complication are often responsable of poor prognosis. One of these complication vasculitis is steel not weel understood. There are only few study about it on children.

It is a retrospective study about 17 cases of chil which bacterial meningitis coupled wiethe cerebral vasculitis, the Investigators will describe epidemiology, bacteriology, evolution and corticosteroid treatment in this patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • bacterial meningitis with LCR confirmation

Exclusion criteria:

  • tuberculous meningitis, immunosuppressor treatment, material like DVP
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Found a difference demographic data1 day

Found a difference demographic data between population A and B (gender)

Found a difference Inflammatory parkers1 day

Found a difference Inflammatory parkers between population A and B

Found a difference Clinical manifestation1 day

Found a difference Clinical manifestation between population A and B

Found a difference Infectious agent1 day

Found a difference Infectious agent between population A and B

Secondary Outcome Measures
NameTimeMethod
In the A group, studying the relationship between prescription of steroids pulse and final outcome and presence of sequelae.1 day

Sequelae will be defined by the presence of one of this element : : presence of seizure within the next 6 month before the last survey, necessity of antiepileptic treatment, development delay, presence of neurologic deficiency(palsy), persistence of abnormality on neuroimaging.

Found a difference in the evolution of the diseases between group A and B1 day

The data analysed will be : presence of seizure within the next 6 month before the last survey, necessity of antiepileptic treatment, development delay, presence of neurologic deficiency(palsy), persistence of abnormality on neuroimaging.

Trial Locations

Locations (1)

Uhmontpellier

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath